# CD19/CD20 Dual-CAR-T in B-cell Leukemia Patients

> **NCT04260945** · PHASE1 · COMPLETED · sponsor: **Hebei Yanda Ludaopei Hospital** · enrollment: 12 (actual)

## Conditions studied

- B-cell Leukemia

## Interventions

- **BIOLOGICAL:** CD19/CD20 Dual-CAR-T cells

## Key facts

- **NCT ID:** NCT04260945
- **Lead sponsor:** Hebei Yanda Ludaopei Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-10
- **Primary completion:** 2021-10-10
- **Final completion:** 2022-02-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04260945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04260945, "CD19/CD20 Dual-CAR-T in B-cell Leukemia Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04260945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*